SNMMI 2017 in Denver

Come see Cubresa’s NuPET™ at the 2017 SNMMI Annual Meeting in Denver Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging Become empowered with simultaneous multimodal molecular & functional preclinical imaging with the high-performance quantitation of PET and the excellent soft tissue contrast

MPIC 2017 in Nashville

Cubresa at the Third Annual MPIC Meeting in Nashville Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging As an industry sponsor of the 3rd Annual Midwest Preclinical Imaging Consortium (MPIC), we enjoyed meeting all the attendees while in Nashville at the

ISMRM 2017 in Honolulu

Come see Cubresa’s NuPET™ in Booth 125 at the ISMRM 2017 Annual Meeting & Exhibition in Honolulu Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging We certainly enjoyed our time at this year’s International Society for Magnetic Resonance in Medicine in

EMIM 2017 in Cologne

Thank you for coming to see Cubresa’s NuPET™ at the EMIM 2017 Meeting & Exhibition in Cologne Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging This year’s European Molecular Imaging Meeting at Hörsaalgebäude University in Cologne, April 5 to 7,

Preclinical PET Scanner for Simultaneous PET/MRI Installed at the University of Arizona Could Contribute to Improved Tumor Assessment

Preclinical PET Scanner for Simultaneous PET/MRI Installed at the University of Arizona Could Contribute to Improved Tumor Assessment

Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular